PT FRESENIUS KABI COMBIPHAR

PT Fresenius Kabi Combiphar is primarily a factory (manufacturer).

Company Introduction:

PT Fresenius Kabi Combiphar is a pharmaceutical company based in Indonesia, established as a strategic partnership or joint venture between Fresenius Kabi and Combiphar.

Fresenius Kabi is a globally operating healthcare company specializing in intravenously administered generic drugs, infusion therapies, clinical nutrition, and medical devices for their administration. With a strong commitment to improving the quality of life for critically and chronically ill patients, Fresenius Kabi operates numerous manufacturing facilities worldwide, adhering to stringent international quality standards.

Combiphar is one of Indonesia's prominent pharmaceutical companies, possessing extensive experience in the local market, robust distribution networks, and established manufacturing capabilities.

The collaboration through PT Fresenius Kabi Combiphar leverages Fresenius Kabi's global expertise, advanced pharmaceutical technologies, and high-quality product portfolio with Combiphar's deep understanding of the Indonesian healthcare landscape and local operational strengths. This entity primarily focuses on the local production and distribution of essential pharmaceutical products in Indonesia. Its offerings typically include a range of life-saving medicines, such as infusion solutions, parenteral nutrition products, and generic injectables, critical for patient care in hospitals and clinical settings. Therefore, its core business function involves manufacturing these pharmaceutical products within Indonesia, making it a key local producer rather than solely a trading company.

Here are some of the products manufactured or marketed by PT Fresenius Kabi Combiphar in Indonesia:

* Generic Injectables

* Anti-Infectives

* Oncology Drugs

* Parenteral Nutrition

* Medical Devices

* I.V. Fluids

* Anesthetics

* Analgesics

* Critical Care Products

* Biosimilars

* Transfusion Technology